42
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Development and Validation of a RP-HPLC Method for Estimation of Montelukast Sodium in Bulk and in Tablet Dosage Form

      other

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The present work describes a simple, precise and accurate HPLC method for estimation of montelukast sodium in bulk and in tablet dosage form. The separation was achieved by using octadecylsilane column (C18) and acetonitrile:1 mM sodium acetate adjusted to pH 6.3 with acetic acid in proportion of 90:10 v/v as mobile phase, at a flow rate of 1.5 ml/min. Detection was carried out at 285 nm. The retention time of montelukast sodium was found to be 3.4 min. The limit of detection was found 1.31 µg/ml and limit of quantification 3.97 µg/ml. The accuracy and reliability of the proposed method was ascertained by evaluating various validation parameters like linearity (1-100 µg/ml), precision, accuracy and specificity according to ICH guidelines. The proposed method provides an accurate and precise quality control tool for routine analysis of montelukast sodium in bulk and in tablet dosage form.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: not found
          • Article: not found

          Martindale, the complete drug reference

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Essentials of Medical Pharmacology

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.

              We tested the hypothesis that adding montelukast to budesonide would improve asthma control in children with inhaled glucocorticoid-dependent persistent asthma. In a multicenter, randomized, double-blind, crossover study, we compared the benefit of adding montelukast, 5 mg, or placebo once daily to budesonide, 200 microg, twice daily. After a 1-month run-in with budesonide, 200 microg, twice daily, 279 children were randomized to montelukast or placebo. The mean +/- SD age was 10.4 +/- 2.2 years, the mean forced expiratory volume in 1 second (FEV(1)) was 77.7% +/- 10.6% predicted, and reversibility was 18.1% +/- 12.9%. Compared with adding placebo to budesonide, adding montelukast produced significant improvements in mean percent change from baseline FEV(1) (P =.062 [P =.010 for per-protocol analysis]), mean absolute change from baseline FEV(1) (P =.040), mean increase from baseline in morning (P =.023) and evening (P =.012) peak expiratory flows, decrease in exacerbation days by approximately 23% (P <.001), decreased beta2-agonist use (P =.013), and reduced blood eosinophil counts (P <.001). The treatments did not differ significantly with regard to safety. Montelukast, 5 mg, added to budesonide improved asthma control significantly, indicated by a small additive effect on lung function and a clinically relevant decrease in asthma exacerbation days.
                Bookmark

                Author and article information

                Journal
                Indian J Pharm Sci
                IJPhS
                Indian Journal of Pharmaceutical Sciences
                Medknow Publications (India )
                0250-474X
                1998-3743
                Mar-Apr 2010
                : 72
                : 2
                : 235-237
                Affiliations
                Research and Development Division, Indian Pharmacopoeia Commission, Sector-23, Rajnagar, Ghaziabad-201 002, India
                [1 ]Department of Pharmaceutical Analysis, Faculty of Pharmacy, Vinayaka Mission University, Salem-636 015, India
                Author notes
                [* ] Address for correspondence E-mail: raman19662002@ 123456yahoo.co.in
                Article
                IJPhS-72-235
                10.4103/0250-474X.65023
                2929785
                20838530
                7e84c57c-18f3-4b08-a557-4fd39dd8fe18
                © Indian Journal of Pharmaceutical Sciences

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 04 March 2010
                : 31 October 2009
                : 05 May 2009
                Categories
                Short Communication

                Pharmacology & Pharmaceutical medicine
                method development and validation,montelukast,hplc
                Pharmacology & Pharmaceutical medicine
                method development and validation, montelukast, hplc

                Comments

                Comment on this article